Victoria Niklas
Directeur/Bestuurslid bij FIBROBIOLOGICS, INC.
Vermogen: 91 350 $ op 31-05-2024
Actieve functies van Victoria Niklas
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| FIBROBIOLOGICS, INC. | Directeur/Bestuurslid | 08-04-2021 | - |
| Independent Dir/Board Member | 08-04-2021 | - | |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2022 | - |
Loopbaan van Victoria Niklas
Eerdere bekende functies van Victoria Niklas
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Prolacta Bioscience, Inc.
 Prolacta Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Prolacta Bioscience, Inc. provides specialty formulations of human milk for the nutritional needs of premature and critically ill infants. Its products include Prolact+ H2MF, Prolact+4, Prolact+6, Prolact+8, Prolact+10 and Neo20. The company was founded by Elena Taggart Medo in1999 and is headquartered in Duarte, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2016 | 01-01-2019 |
UCLA Health Systems
 UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | Corporate Officer/Principal | 01-01-2014 | 01-01-2016 |
| Nemours Children's Clinic, Inc. | Corporate Officer/Principal | 01-01-2012 | 01-01-2014 |
Opleiding van Victoria Niklas
| Harvard University | Graduate Degree |
| Goucher College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Verenigd Koninkrijk | 2 |
| 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 2 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Prolacta Bioscience, Inc.
Prolacta Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Prolacta Bioscience, Inc. provides specialty formulations of human milk for the nutritional needs of premature and critically ill infants. Its products include Prolact+ H2MF, Prolact+4, Prolact+6, Prolact+8, Prolact+10 and Neo20. The company was founded by Elena Taggart Medo in1999 and is headquartered in Duarte, CA. | Health Technology |
UCLA Health Systems
UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | Health Services |
| Nemours Children's Clinic, Inc. | |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Commercial Services |
| FibroBiologics, Inc. |
- Beurs
- Insiders
- Victoria Niklas
- Ervaring
